Flying under the radar: the immunobiology of hepatitis C.
暂无分享,去创建一个
[1] C. Rice,et al. Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. , 2006, Blood.
[2] O. Pybus,et al. Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution , 2006, Hepatology.
[3] X. Mariette,et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. , 2002, The New England journal of medicine.
[4] M. Brook,et al. Treatment of hepatitis. , 1988, The Journal of hospital infection.
[5] G. Missale,et al. The Impairment of CD8 Responses Limits the Selection of Escape Mutations in Acute Hepatitis C Virus Infection1 , 2005, The Journal of Immunology.
[6] F. Chisari,et al. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. , 2005, Immunity.
[7] D. Accapezzato,et al. Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection , 2004 .
[8] A. Bertoletti,et al. The influence of T cell cross‐reactivity on HCV‐peptide specific human T cell response , 2006, Hepatology.
[9] J. Prieto,et al. Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses , 2003, Journal of Virology.
[10] Grégoire Altan-Bonnet,et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction , 2006, Nature.
[11] M. Mayo. Extrahepatic manifestations of hepatitis C infection. , 2003, The American journal of the medical sciences.
[12] H. Blum,et al. Intrahepatic CD8+ T‐cell failure during chronic hepatitis C virus infection , 2005, Hepatology.
[13] L. Romics,et al. Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell Differentiation1 , 2003, The Journal of Immunology.
[14] O. Pybus,et al. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes , 2006, Journal of viral hepatitis.
[15] G. Lauer,et al. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C , 2005, Hepatology.
[16] C. Rice,et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[17] Robert S. Brown. Hepatitis C and liver transplantation , 2005, Nature.
[18] B. Rehermann,et al. The liver as an immunological organ , 2006, Hepatology.
[19] William M. Lee,et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] N. Afdhal,et al. Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells1 , 2004, The Journal of Immunology.
[22] D. Tyrrell,et al. Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy1 , 2006, The Journal of Immunology.
[23] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[24] Andrew H Talal,et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. , 2005, Blood.
[25] K. Reddy,et al. T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C , 2005, Hepatology.
[26] L. Wodicka,et al. Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Deborah Chavez,et al. Genomic response to interferon‐α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics , 2006, Hepatology.
[28] M. Alter,et al. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. , 1996, JAMA.
[29] Y. Tominaga,et al. Expression of IFN-inducible protein-10 in chronic hepatitis. , 1997, Journal of immunology.
[30] M. Davis,et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] Raymond M. Welsh,et al. No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.
[32] N. Gruener,et al. Detection of functionally altered hepatitis C virus‐specific CD4+ T cells in acute and chronic hepatitis C , 2003, Hepatology.
[33] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[34] B. Rehermann,et al. Hepatitis C virus infection: when silence is deception. , 2003, Trends in immunology.
[35] Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment , 2003 .
[36] J. Bennink,et al. Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells , 2001, Journal of Virology.
[37] Stanley M Lemon,et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] Stuart C. Ray,et al. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus , 2005, The Journal of experimental medicine.
[39] M. Alter,et al. Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.
[40] E. Shin,et al. Private aspects of heterologous immunity , 2005, The Journal of experimental medicine.
[41] Bin Li,et al. Full-Breadth Analysis of CD8+ T-Cell Responses in Acute Hepatitis C Virus Infection and Early Therapy , 2005, Journal of Virology.
[42] T. Layden,et al. Hepatitis C Kinetics: Mathematical Modeling of Viral Response to Therapy , 2000, Seminars in liver disease.
[43] R. Bartenschlager,et al. Interferon‐γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs , 2002 .
[44] R. Welsh,et al. CD8 T cell responses to viral infections in sequence , 2004, Cellular microbiology.
[45] S. Kalams,et al. Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape , 2004, The Journal of experimental medicine.
[46] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[47] R. Doms,et al. Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR , 2003, Journal of Virology.
[48] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[49] C. Walker,et al. Mutational escape from CD8+ T cell immunity , 2005, The Journal of experimental medicine.
[50] B. Bartosch,et al. C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles* , 2004, Journal of Biological Chemistry.
[51] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[52] J. Bukh. A critical role for the chimpanzee model in the study of hepatitis C , 2004, Hepatology.
[53] Todd M. Allen,et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. , 2004, Gastroenterology.
[54] R. Steinman,et al. Dendritic cell maturation by innate lymphocytes , 2005, The Journal of experimental medicine.
[55] N. Hayashi,et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. , 1999, Journal of immunology.
[56] H. Agut,et al. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. , 2003, Blood.
[57] Charles M. Rice,et al. Unravelling hepatitis C virus replication from genome to function , 2005, Nature.
[58] E. Wherry,et al. Memory CD8 T-Cell Differentiation during Viral Infection , 2004, Journal of Virology.
[59] K. Sugimoto,et al. Suppression of HCV‐specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection , 2003, Hepatology.
[60] J. Sidney,et al. Cellular immune selection with hepatitis C virus persistence in humans , 2005, The Journal of experimental medicine.
[61] S. Lemon,et al. Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in Hepatocytes* , 2005, Journal of Biological Chemistry.
[62] C. Rice,et al. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. , 2005, The Journal of infectious diseases.
[63] P. Klenerman,et al. Immunity to hepatitis C virus: stunned but not defeated. , 2002, Microbes and infection.
[64] B. Bartosch,et al. Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes , 2003, The Journal of experimental medicine.
[65] D. Barton,et al. Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. , 2002, RNA.
[66] Ronald N Germain,et al. Cooperation between CD4+ and CD8+ T cells: when, where, and how. , 2006, Annual review of immunology.
[67] C. Rice,et al. Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C , 2005, Journal of Virology.
[68] I. N. Crispe,et al. Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.
[69] B. Walker,et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. , 2003, The Journal of clinical investigation.
[70] G. McCaughan,et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. , 2004, The Journal of clinical investigation.
[71] C. Tseng,et al. Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.
[72] M. Giménez-Barcons,et al. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[73] Takashi Taguchi,et al. Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. , 2004, The Journal of general virology.
[74] P. Klenerman,et al. The dynamics of T‐lymphocyte responses during combination therapy for chronic hepatitis C virus infection , 2002, Hepatology.
[75] G. Sen,et al. Viruses and interferons. , 2001, Annual review of microbiology.
[76] A. Weiner,et al. Vaccination of chimpanzees against infection by the hepatitis C virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[77] N. Hayashi,et al. Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection1 , 2004, The Journal of Immunology.
[78] J. Hoofnagle,et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C , 2004, Hepatology.
[79] A. Sette,et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.
[80] Todd M. Allen,et al. CD8 Epitope Escape and Reversion in Acute HCV Infection , 2004, The Journal of experimental medicine.
[81] A. Bertoletti,et al. Heterologous T cell immunity in severe hepatitis C virus infection , 2005, The Journal of experimental medicine.
[82] D. Vlahov,et al. Protection against persistence of hepatitis C , 2002, The Lancet.
[83] E. Wherry,et al. Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.
[84] E. Keeffe,et al. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. , 2001, Blood.
[85] C. Rice,et al. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees , 2004, Hepatology.
[86] R. Bartenschlager. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. , 2006, Current opinion in microbiology.
[87] B. Walker,et al. Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection , 2002, Journal of Virology.
[88] S. Friedman,et al. Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications , 2004, Nature Clinical Practice Gastroenterology &Hepatology.
[89] C. Rice,et al. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. , 2004, Blood.
[90] H J Alter,et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.
[91] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[92] S. Ray,et al. Humoral immune response in acute hepatitis C virus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] M. Gale,et al. Evasion of intracellular host defence by hepatitis C virus , 2005, Nature.
[94] P. Klenerman,et al. Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection , 2003, Journal of Virology.
[95] M. Houghton,et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[96] M. Kronenberg,et al. Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.
[97] T. Colby,et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C , 2005, Hepatology.
[98] F. Weber,et al. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. , 2006, Antiviral research.
[99] G. Freeman,et al. Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.
[100] C. Walker,et al. Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.
[101] T. Braciale,et al. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. , 2000, The Journal of clinical investigation.
[102] M. Manns,et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C , 2000, Nature Medicine.
[103] J. Ghrayeb,et al. Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection , 2003, The Journal of experimental medicine.
[104] O. Hermine,et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. , 2006, Blood.
[105] R. Purcell,et al. Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[106] H. Ljunggren,et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance , 2000, Nature Medicine.
[107] Salim I. Khakoo,et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.
[108] S. Ray,et al. Cross-Genotype Immunity to Hepatitis C Virus , 2004, Journal of Virology.
[109] R. Lanford,et al. DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection , 2001, Journal of Virology.
[110] C. Walker,et al. Characterization of HCV‐specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee , 2003, Hepatology.
[111] C. Rice,et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[112] Rolf M. Zinkernagel,et al. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.
[113] F. Celada,et al. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. , 2006, The Journal of clinical investigation.
[114] Charles M. Rice,et al. HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help , 2003, Science.
[115] R. Ahmed,et al. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.
[116] Jin-Xiong She,et al. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line , 2003, Hepatology.
[117] A. J. McMichael,et al. Immunology: The original sin of killer T cells , 1998, Nature.
[118] M. Brunetto,et al. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. , 2005, Journal of hepatology.
[119] D. Burton. Antibodies, viruses and vaccines , 2002, Nature Reviews Immunology.
[120] M. Gale,et al. CARD games between virus and host get a new player. , 2006, Trends in immunology.
[121] G. Leroux-Roels. Development of prophylactic and therapeutic vaccines against hepatitis C virus , 2005, Expert review of vaccines.
[122] B. Chain,et al. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? , 2005, The Lancet. Infectious diseases.
[123] Spyros A. Kalams,et al. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.
[124] P. Simmonds,et al. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. , 1998, The Journal of general virology.
[125] M. Diago,et al. Increased circulating and intrahepatic T‐cell‐specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy , 2004, Alimentary pharmacology & therapeutics.
[126] Todd M. Allen,et al. Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes1 , 2005, The Journal of Immunology.
[127] C. Rice,et al. Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus , 2004, Journal of Virology.
[128] D. Lavillette,et al. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee , 2005, Hepatology.
[129] M. Lai,et al. Hepatitis C Virus Infection Activates the Immunologic (Type II) Isoform of Nitric Oxide Synthase and Thereby Enhances DNA Damage and Mutations of Cellular Genes , 2004, Journal of Virology.
[130] S. Lemon,et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[131] C. Guha,et al. Cell Culture Models and Animal Models of Viral Hepatitis. Part II: Hepatitis C , 2005, Lab Animal.
[132] S. Kamal,et al. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. , 2002, Gastroenterology.
[133] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[134] McCollum Rw. The natural history of hepatitis. , 1969 .
[135] N. Afdhal. The natural history of hepatitis C. , 2004, Seminars in liver disease.
[136] M. Lai,et al. Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection , 2003, Journal of Virology.
[137] B. Walker,et al. Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities , 2002, Journal of Virology.
[138] Alan S. Perelson,et al. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .
[139] O. Schwartz,et al. DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2* , 2003, Journal of Biological Chemistry.
[140] D. Stump,et al. The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. , 2005, Seminars in liver disease.
[141] D. Ho,et al. Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner , 2004, Journal of Virology.
[142] C. Walker,et al. Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.
[143] A. Hughes,et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.
[144] K. Shimotohno,et al. Effects of Mutation in Hepatitis C Virus Nonstructural Protein 5A on Interferon Resistance Mediated by Inhibition of PKR Kinase Activity in Mammalian Cells , 2001, Microbiology and immunology.
[145] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[146] M. Houghton,et al. Effects of interferon treatment on the antiviral T‐cell response in hepatitis C virus genotype 1b‐ and genotype 2c‐infected patients , 1997, Hepatology.
[147] F. Chisari,et al. Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.
[148] J. McHutchison,et al. American Gastroenterological Association technical review on the management of hepatitis C. , 2006, Gastroenterology.
[149] H. Blum,et al. T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection , 2005, Journal of Virology.
[150] P. Parham. NK Cells Lose Their Inhibition , 2004, Science.
[151] Colin W Shepard,et al. Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.
[152] F. Chisari,et al. Stealth and Cunning: Hepatitis B and Hepatitis C Viruses , 2005, Journal of Virology.
[153] T. Salazar-Mather,et al. Cytokine and chemokine networks: pathways to antiviral defense. , 2006, Current topics in microbiology and immunology.
[154] T. Santantonio,et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.
[155] A. Perelson,et al. Viral dynamics and response differences in HCV‐infected African American and white patients treated with IFN and ribavirin , 2003, Hepatology.
[156] P Parham,et al. Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.
[157] Ralf Bartenschlager,et al. Novel insights into hepatitis C virus replication and persistence. , 2004, Advances in virus research.
[158] Roger Williams,et al. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. , 2000, Gastroenterology.
[159] F. Chisari,et al. Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.
[160] J. Hiscott,et al. MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.
[161] Ruslan Medzhitov,et al. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.
[162] Zhijian J. Chen,et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[163] F. Zoulim,et al. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. , 2001, Gastroenterology.
[164] S. Nuti,et al. Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.
[165] C. Cheng‐Mayer,et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[166] W. Olson,et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[167] J. Heathcote,et al. Treatment of hepatitis C , 2005, Journal of viral hepatitis.
[168] S. Emerson,et al. In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[169] J. Piette,et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. , 2004, Blood.
[170] B. Rehermann,et al. Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.
[171] R. Purcell,et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[172] S. Emerson,et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[173] C. Rice,et al. Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge , 2002, Journal of Virology.